SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,536,000 | -63.0% | 18,072 | -67.9% | 0.01% | -70.8% |
| Q2 2020 | $9,566,000 | +168.3% | 56,296 | +82.2% | 0.05% | +108.7% |
| Q1 2020 | $3,566,000 | +72.4% | 30,904 | +70.7% | 0.02% | +228.6% |
| Q4 2019 | $2,069,000 | +404.6% | 18,106 | +205.6% | 0.01% | +600.0% |
| Q2 2019 | $410,000 | -47.2% | 5,924 | -44.1% | 0.00% | -66.7% |
| Q1 2019 | $776,000 | +98.0% | 10,589 | +53.1% | 0.00% | +50.0% |
| Q4 2018 | $392,000 | -69.8% | 6,917 | -58.9% | 0.00% | -60.0% |
| Q3 2018 | $1,296,000 | +130.2% | 16,814 | +98.4% | 0.01% | +150.0% |
| Q2 2018 | $563,000 | -19.9% | 8,476 | -36.9% | 0.00% | -33.3% |
| Q1 2018 | $703,000 | – | 13,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |